Monarch Partners Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.15M Buy
35,645
+2,285
+7% +$134K 0.63% 72
2022
Q3
$2.02M Buy
+33,360
New +$1.05M 0.61% 81

Other funds holding PRTA

Monarch Partners Asset Management's PRTA Position: Q4 2022 in Review

Monarch Partners Asset Management increased its Prothena Corp (PRTA) stake by 6.8% in Q4 2022, buying an estimated $134K and bringing the position to 35,645 shares worth $2.15M. The position accounts for 0.63% of the portfolio, ranked #72.

Monarch Partners Asset Management first reported a position in PRTA in Q3 2022 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

  • Monarch Partners Asset Management held 35,645 shares of Prothena Corp worth $2.15M as of Q4 2022.
  • Monarch Partners Asset Management bought 2,285 Prothena Corp shares in Q4 2022, an estimated $134K.
  • Prothena Corp made up 0.63% of Monarch Partners Asset Management's portfolio in Q4 2022, its #72 holding.
  • Monarch Partners Asset Management first reported a position in Prothena Corp in Q3 2022 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.